MedPath

Evaluation, Psychological Intervention and Follow-up Study of Anxiety and Depression in Stable COPD Patients

Not Applicable
Conditions
Depression
COPD
Anxiety
Interventions
Behavioral: Baduanjin qigong
Registration Number
NCT02413840
Lead Sponsor
Huimin Gong
Brief Summary

This study expect to investigate psychological intervention (Baduanjin qigong) in COPD patients combined with anxiety and/or depression.

Detailed Description

Anxiety and depression is one of the most common complications of COPD patients.This research use psychological questionnaires to evaluate the stage of COPD patients with anxiety and/or depression(asymptomatic, subclinical,clinical). The subclinical type will divided into the treatment group of Baduanjin qigong,and the control group. Two groups are all receive the same psychological counseling, the treatment group also receive further treatment of Baduanjin qigong under the guidance of medical staff. The treatment along for 1 year. Two groups were followed up for 2 years, dynamically observe the stage of anxiety and depression,the number of exacerbations,lung function,etc.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Diagnosed of COPD
  • In stable phase
  • FEV1%predicted <80.
Exclusion Criteria
  • Cancer
  • Severe cerebrovascular disease
  • Severe arrhythmia,cardiac insufficiency
  • Alzheimer's disease
  • Mental illness
  • Severe liver disfunction
  • Severe renal disfunction
  • Physical activity disable.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Baduanjin qigong groupBaduanjin qigongDoing exercise of Baduanjin qigong under the guidance of medical staff;psychological counseling at the same time.
Primary Outcome Measures
NameTimeMethod
stage of anxiety and depression ((Hospital Anxiety and Depression Scale)one year

use psychological questionnaires(Hospital Anxiety and Depression Scale,etc)to evaluate the stage of anxiety and/or depression

Secondary Outcome Measures
NameTimeMethod
the number of acute exacerbationsone year
lung function (pulmonary function test(20 minutes after inhaled 400ug albuterol),the forced expiratory volume in 1 second(FEV1)will be detected)one year

use pulmonary function test(20 minutes after inhaled 400ug albuterol),the forced expiratory volume in 1 second(FEV1)will be detected.

Trial Locations

Locations (1)

Beijing institute of respiratory diseases

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath